U.S. Court of Appeals for the Federal Circuit, 2026

Taiho Pharmaceutical Co., Ltd. v. Msn Laboratories Private Ltd.

Taiho Pharmaceutical Co., Ltd. v. Msn Laboratories Private Ltd.
U.S. Court of Appeals for the Federal Circuit · Decided April 28, 2026
Taiho Pharmaceutical Co., Ltd. v. Msn Laboratories Private Ltd.

Opinion

Case: 25-1407 Document: 39 Page: 1 Filed: 04/28/2026

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit

______________________

TAIHO PHARMACEUTICAL CO., LTD., TAIHO

ONCOLOGY, INC., Plaintiffs-Appellants v.

MSN LABORATORIES PRIVATE LTD., MSN

PHARMACEUTICALS, INC., Defendants-Cross-Appellants ______________________

2025-1407, 2025-1453 ______________________

Appeals from the United States District Court for the District of Delaware in No. 1:19-cv-02342-JLH, Judge Jen- nifer L. Hall.

______________________ ORDER

The parties submit a joint stipulation to voluntarily dismiss the above-captioned appeals with prejudice pursu- ant to Federal Rule of Appellate Procedure 42(b), with each side to bear its own costs.

This court generally does not specify whether a dismis- sal of a matter is with or without prejudice.

Upon consideration thereof, IT IS ORDERED THAT:

Case: 25-1407 Document: 39 Page: 2 Filed: 04/28/2026 2 TAIHO PHARMACEUTICAL CO., LTD. v. MSN LABORATORIES

PRIVATE LTD. (1) The appeals are dismissed. (2) Each side shall bear its own costs.

FOR THE COURT April 28, 2026

Date ISSUED AS A MANDATE: April 28, 2026

Case-law data current through September 30, 2026. Source: CourtListener bulk data.